Detail page

Knowledge Web

Person

Florian Bassermann (1973-)

Arzt

Name	Florian Bassermann
Time	1973- (Date of birth and death)
Place	München (Geburtsort) Deutschland
Academic degree	Dr. med.
Profession	Arzt (characteristic profession)
Variant	Florian Christoph Bassermann
Further information	Diss. Fakultät für Medizin, Habil.-Schr. Fach Innere Medizin an der Medizinischen Fakultät der Techn. Univ. München
Record type	Person
GND-Identifier	123743109
Record ID	123743109
Involved in show all B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformation FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges CXCR4-targeted theranostics in hematooncology: opportunities and challenges CXCR4-targeted theranostics in hematooncology: opportunities and challenges = CXCR4-gerichtete Theranostics in der Hämato-Onkologie: Möglichkeiten und Herausforderungen Exploiting the ubiquitin system to identify novel vulnerabilities in B-cell malignancies and lung adenocarcinoma Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification Actionable loss of SLF2 drives B‐cell lymphomagenesis and impairs the DNA damage response Antagonistic activities of CDC14B and CDK1 on USP9X regulate WT1-dependent mitotic transcription and survival Dissecting aberrant host-microbiota interactions in a model of TNF-driven intestinal inflammation Elevated RIPK3 correlates with disease burden in myelofibrosis Leukocytes carrying Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations invade Human Atherosclerotic Plaques The OTUD6B‐LIN28B‐MYC axis determines the proliferative state in multiple myeloma Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma Aberrant cell cycle regulatory ubiquitin networks in B-cell malignancies Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma FBXL 13 directs the proteolysis of CEP 192 to regulate centrosome homeostasis and cell migration IMiDs mediate their anti-myeloma activity via destabilization of the CD147/MCT1 complex The role of the deubiquitinase USP24 in multiple myeloma USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B‐cell lymphoma USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B‐cell lymphoma SCF und ACP-C Ubiquitin-Ligasen als Steuerelemente der Zellzykluskontrolle und der DNA-Schaden Antwort : Bedeutung für die Tumorentstehung Identifizierung und Charakterisierung der Interaktion von Bcr-Abl mit dem Protoonkogen p95-Vav

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Florian Bassermann (1973-)

B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformation

FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells

The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities

CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges

CXCR4-targeted theranostics in hematooncology: opportunities and challenges

CXCR4-targeted theranostics in hematooncology: opportunities and challenges = CXCR4-gerichtete Theranostics in der Hämato-Onkologie: Möglichkeiten und Herausforderungen

Exploiting the ubiquitin system to identify novel vulnerabilities in B-cell malignancies and lung adenocarcinoma

Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification

Actionable loss of SLF2 drives B‐cell lymphomagenesis and impairs the DNA damage response

Antagonistic activities of CDC14B and CDK1 on USP9X regulate WT1-dependent mitotic transcription and survival

Dissecting aberrant host-microbiota interactions in a model of TNF-driven intestinal inflammation

Elevated RIPK3 correlates with disease burden in myelofibrosis

Leukocytes carrying Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations invade Human Atherosclerotic Plaques

The OTUD6B‐LIN28B‐MYC axis determines the proliferative state in multiple myeloma

Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma

Aberrant cell cycle regulatory ubiquitin networks in B-cell malignancies

Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies

Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies

Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM

Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany

USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma

FBXL 13 directs the proteolysis of CEP 192 to regulate centrosome homeostasis and cell migration

IMiDs mediate their anti-myeloma activity via destabilization of the CD147/MCT1 complex

The role of the deubiquitinase USP24 in multiple myeloma

USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B‐cell lymphoma

USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B‐cell lymphoma

SCF und ACP-C Ubiquitin-Ligasen als Steuerelemente der Zellzykluskontrolle und der DNA-Schaden Antwort : Bedeutung für die Tumorentstehung

Identifizierung und Charakterisierung der Interaktion von Bcr-Abl mit dem Protoonkogen p95-Vav